Despite the growing interest in PSMA-labeled ligand PET/CT diagnostics in recent years, the number of publications evaluating the diagnostic accuracy of this method in ccRCC/RCC patients is still limited. The gene discussed is FOLH1; the disease is nonpapillary renal cell carcinoma.